Corrigendum to “Safety and efficacy of odronextamab in patients with relapsed or refractory follicular lymphoma”
Titel:
Corrigendum to “Safety and efficacy of odronextamab in patients with relapsed or refractory follicular lymphoma”
Auteur:
Kim, T.M. Taszner, M. Novelli, S. Cho, S.-G. Villasboas, J.C. Merli, M. Jiménez-Ubieto, A. Tessoulin, B. Poon, L.M. Tucker, D. Walewski, J. Yi, S. Song, Y. Chong, G. Bachy, E. Guidez, S. Alonso, A. Jagadeesh, D. Zhang, W. Magnano, L. Iskierka-Jażdżwska, E. Tani, M. Shen, B. Uppala, A. Zhu, M. Shariff, S. Brouwer-Visser, J. Chaudhry, A. Mohamed, H. Ambati, S. Luminari, S.